Literature DB >> 35610397

Understanding bias in probabilistic analysis in model-based health economic evaluation.

Xuanqian Xie1, Alexis K Schaink2, Sichen Liu3, Myra Wang2, Andrei Volodin4,5.   

Abstract

Guidelines of economic evaluations suggest that probabilistic analysis (using probability distributions as inputs) provides less biased estimates than deterministic analysis (using point estimates) owing to the non-linear relationship of model inputs and model outputs. However, other factors can also impact the magnitude of bias for model results. We evaluate bias in probabilistic analysis and deterministic analysis through three simulation studies. The simulation studies illustrate that in some cases, compared with deterministic analyses, probabilistic analyses may be associated with greater biases in model inputs (risk ratios and mean cost estimates using the smearing estimator), as well as model outputs (life-years in a Markov model). Point estimates often represent the most likely value of the parameter in the population, given the observed data. When model parameters have wide, asymmetric confidence intervals, model inputs with larger likelihoods (e.g., point estimates) may result in less bias in model outputs (e.g., costs and life-years) than inputs with lower likelihoods (e.g., probability distributions). Further, when the variance of a parameter is large, simulations from probabilistic analyses may yield extreme values that tend to bias the results of some non-linear models. Deterministic analysis can avoid extreme values that probabilistic analysis may encounter. We conclude that there is no definitive answer on which analytical approach (probabilistic or deterministic) is associated with a less-biased estimate in non-linear models. Health economists should consider the bias of probabilistic analysis and select the most suitable approach for their analyses.
© 2022. Crown.

Entities:  

Keywords:  Bias; Deterministic analysis; Economic evaluation; Model; Probabilistic analysis

Year:  2022        PMID: 35610397     DOI: 10.1007/s10198-022-01472-8

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  7 in total

1.  Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra.

Authors:  Karl Claxton; Mark Sculpher; Chris McCabe; Andrew Briggs; Ron Akehurst; Martin Buxton; John Brazier; Tony O'Hagan
Journal:  Health Econ       Date:  2005-04       Impact factor: 3.046

2.  Handling input correlations in pharmacoeconomic models.

Authors:  Klemen Naveršnik; Klemen Rojnik
Journal:  Value Health       Date:  2012-02-17       Impact factor: 5.725

3.  Characterizing Heterogeneity Bias in Cohort-Based Models.

Authors:  Elamin H Elbasha; Jagpreet Chhatwal
Journal:  Pharmacoeconomics       Date:  2015-08       Impact factor: 4.981

Review 4.  Cost-Effectiveness of Current and Emerging Treatments of Varicose Veins.

Authors:  David Epstein; Sarah Onida; Roshan Bootun; Marta Ortega-Ortega; Alun H Davies
Journal:  Value Health       Date:  2018-03-15       Impact factor: 5.725

Review 5.  Management of varicose veins and venous insufficiency.

Authors:  Allen Hamdan
Journal:  JAMA       Date:  2012-12-26       Impact factor: 56.272

6.  The design of simulation studies in medical statistics.

Authors:  Andrea Burton; Douglas G Altman; Patrick Royston; Roger L Holder
Journal:  Stat Med       Date:  2006-12-30       Impact factor: 2.373

7.  Using simulation studies to evaluate statistical methods.

Authors:  Tim P Morris; Ian R White; Michael J Crowther
Journal:  Stat Med       Date:  2019-01-16       Impact factor: 2.497

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.